4//SEC Filing
Weber David M 4
Accession 0001179110-21-009901
CIK 0000815094other
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 4:29 PM ET
Size
21.2 KB
Accession
0001179110-21-009901
Insider Transaction Report
Form 4
ABIOMED INCABMD
Weber David M
Chief Operating Officer
Transactions
- Tax Payment
Common Stock, $.01 par value
2021-11-03$349.76/sh−1,549$541,778→ 131,314 total - Award
Common Stock, $.01 par value
2021-11-03+6,975→ 132,863 total
Holdings
- 15,497(indirect: By Trust)
Common Stock, $.01 par value
- 10,825
Stock Option (Right to Buy)
Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying) - 10,000
Stock Option (right to buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 7,000
Stock Option (right to buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 4,969
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying) - 8,000
Stock Option (right to buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 6,500
Stock Option (right to buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 6,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- [F5]Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001399519
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 8:00 PM ET
- Accepted
- Nov 5, 4:29 PM ET
- Size
- 21.2 KB